Atyr Pharma Stock Widgets and Gadgets
| LIFE Stock | USD 2.00 0.07 3.63% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- LIFE aTyr Pharma
- Latest aTyr Pharma to Present Poster Describing Efzofitimods Mechanism of Action at the American Thoracic Society 2024 International Conference
- LIFE 2.0 0.07
- Low 1.92
- High 2.02
- Alpha 0.0175
- Beta 1.24
- Return On Equity -0.56
- Return On Asset -0.29
- Operating Margin (70.79) %
- Current Valuation 67.47 M
- Shares Outstanding 69.01 M
- Shares Owned By Insiders 2.58 %
- Shares Owned By Institutions 61.73 %
- Number Of Shares Shorted 636.22 K
- Price To Earning (2.19) X
- Price To Book 1.30 X
- Price To Sales 334.89 X
- Revenue 353 K
- Gross Profit (32.42 M)
- EBITDA (52.18 M)
- Net Income (50.39 M)
- Cash And Equivalents 88.55 M
- Cash Per Share 3.09 X
- Total Debt 15.1 M
- Debt To Equity 0.01 %
- Current Ratio 10.08 X
- Book Value Per Share 1.24 X
- Cash Flow From Operations (33.22 M)
- Short Ratio 1.82 X
- Earnings Per Share (0.88) X
- Target Price 22.6
- Number Of Employees 56
- Beta 1.27
- Market Capitalization 138.02 M
- Total Asset 122.07 M
- Retained Earnings (468.02 M)
- Working Capital 86.58 M
- Current Asset 97.95 M
- Current Liabilities 12.15 M
- Net Asset 122.07 M
- Accumulation Distribution 0.0495
- Daily Balance Of Power 0.7
- Rate Of Daily Change 1.04
- Day Median Price 1.97
- Day Typical Price 1.98
- Market Facilitation Index 0.1
- Price Action Indicator 0.065
- Period Momentum Indicator 0.07
- Relative Strength Index 62.28
Market Snapshot Widget Example
DAX Index Germany | 18,704 0.18 | |
Taiwan Weighted Taiwan | 21,258 0.21 | |
PSI 20 Stock Portugal | 6,887 0.48 | |
CROBEX Croatia | 2,826 0.12 | |
Budapest SE Hungary | 68,088 1.11 | |
IDX 30 Jakarta Indonesia | 461.88 0.62 | |
ISEQ 20 Price Ireland | 1,661 0.51 | |
NYSE Comp USA | 18,388 0.39 | |
Tel Aviv 35 Israel | 1,983 1.63 | |
Coreshares Index Tracker South Afric | 1,083 0.09 | |
IPC MEXICO Mexico | 57,583 0.21 | |
KL Technology Malaysia | 71.92 2.54 | |
IBEX 35 Index Spain | 11,328 0.25 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,750 1.15 | |
SPASX Dividend Opportunities Australia | 1,685 0.81 | |
HNX 30 Vietnam | 533.02 2.90 | |
Bucharest BET-NG Romania | 1,223 0.16 | |
AMS Small Cap Netherlands | 1,219 0.46 | |
Oslo Exchange Mutual Norway | 1,367 0.55 | |
BEL Small Belgium | 9,116 1.00 | |
RTSI Index Russia | 1,213 0.44 | |
Basic Materials Brazil | 5,763 0.25 | |
Swiss Leader Price Switzerland | 1,960 0.48 | |
Fondo Mutuo ETF Chile | 1,439 0.59 | |
Athens General Comp Greece | 1,490 0.08 | |
Stock Exchange Of Thailand | 1,384 0.10 | |
PX Prague Stock Czech Repub | 1,561 0.30 | |
THE PHILIPPINE STOCK Philippines | 6,684 0.98 | |
WIG 30 Poland | 3,229 0.39 | |
BIST Electricity Turkey | 609.43 0.76 |
Investing Ideas
In addition to having ATyr Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare ATyr Pharma
Compare ATyr Pharma To Peers
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in aTyr Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.88) | Revenue Per Share 0.01 | Quarterly Revenue Growth (1.00) | Return On Assets (0.29) | Return On Equity (0.56) |
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.